CancerPath has been developed using doctoral research focused on cancer help-seeking behaviour, health inequalities and earlier diagnosis. Every feature is informed by peer-reviewed evidence and established public health frameworks.
CancerPath draws on a broad and rigorous evidence base spanning clinical research, behavioural science and digital health innovation.
CancerPath is grounded in research into the Pathways to Treatment model and the three-delay framework — understanding appraisal delay, illness delay and help-seeking delay, and how digital interventions can reduce each.
Research into how socioeconomic, cultural, geographic and structural factors affect cancer awareness, screening participation and stage at diagnosis — and how digital tools can address these disparities.
Evidence-based approaches to shifting the stage at which cancers are diagnosed — drawing on national audit data, Cancer Research UK research and NHS Long Term Plan ambitions for earlier diagnosis.
Applying established frameworks for digital behaviour change intervention design — including the Behaviour Change Wheel, COM-B model and NICE digital health evidence standards — to cancer awareness and screening engagement.
CancerPath development has been informed by patient and public involvement, ensuring the platform reflects the real experiences, needs and preferences of the communities it is designed to serve.
Research into implementation science and digital health scale-up — understanding what works, for whom and in what contexts — to support sustainable adoption of CancerPath across NHS and community settings.
CancerPath draws on a wide body of evidence spanning clinical guidelines, public health research and digital health innovation literature.
Our development process has been guided by established frameworks for cancer awareness, behaviour change and health equity — ensuring the platform is both clinically credible and practically effective.
Pilot data and outcome metrics will be published as evaluation programmes progress.
Reducing the time between noticing a symptom and recognising it as potentially serious.
Supporting greater participation in NHS bowel, breast, cervical and lung screening programmes.
Addressing psychological and social barriers that cause people to delay seeking professional advice.
Reaching underserved communities and reducing inequalities in cancer awareness and outcomes.
We welcome collaboration with researchers, universities and public health organisations.